It is clear is that the FTC has fully entered the CBD regulatory space and we can expect to hear more from it during the coming months.
The “wild west” days of manufacturing and selling cannabis products outside the sphere of regulatory influence are rapidly coming to an end.
Regardless of how the FDA will eventually regulate CBD, it is abundantly clear that CBD companies should not make medical/disease claims nor market their products as dietary supplements. Doing so at this point is simply foolish.
This article discusses the reasons for smokable hemp’s rapid rise in popularity, why the future of smokable hemp is vital to the hemp industry at large, and the ways in which its legal status is under attack in several states.
As anyone involved in the cannabis industry is aware, the US Food and Drug Administration (FDA) held hearings on May 31, 2019. Ostensibly, the hearing was about “Products Containing Cannabis or Cannabis-Derived Compounds”. In reality, it was about cannabidiol (CBD) in foods, cosmetics, and dietary supplements.
My client’s interaction with DHL reiterates my view that it is usually best to ship hemp and hemp products through the US Postal Service.
I spoke with Elijah Wolfson of Time Magazine about CBD after the FDA hearing. We spoke about several issues, including how to regulate CBD for mass market consumption while protecting the integrity of the clinical drug trials process.
Rod was selected to speak at FDA’s Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing on Friday, May 31, 2019.
Super Lawyers discussed hemp and CBD business law with Rod Kight for a May, 2019 story.
Operation Candy Crush was eventually crushed. All charged were dropped, the store owners’ criminal records were expunged, their stores were ordered reopened, and their seized merchandise was returned. Angry and frustrated, many of them filed a federal lawsuit in the US District Court for the Middle District of Tennessee alleging violations of their civil rights.